1)最新がん統計:がん情報サービス,国立がん研究センター. http://ganjoho.jp/reg_stat/statistics/stat/summary.html(2018年8月30日アクセス)
2)中村恭一,菅野晴夫,高木国夫,他.胃癌組織発生の概念.胃と腸 6:849-861, 1971
3)滝澤登一郎,小池盛雄.病理形態学における微小胃癌─胃癌の組織発生再考.胃と腸 23:791-800, 1988
4)上杉憲幸,菅井有,織笠俊輔,他.微小胃癌の病理─分化型微小胃癌の臨床病理学的および分子病理学的特徴.胃と腸 48:794-808, 2013
5)日本胃癌学会(編).胃癌取扱い規約,第15版.金原出版.2017
6)菅井有,幅野渉,上杉憲幸,他.胃腺腫と腫瘍グレードに基づいた分化型粘膜内胃癌の臨床病理学的および分子病理学的解析.胃と腸 47:203-216, 2012
7)Yao T, Tsutsumi S, Akaiwa Y, et al. Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior. Jpn J Cancer Res 92:755-761, 2001
8)Fujita Y, Kishimoto M, Dohi O, et al. How to adjust endoscopic findings to histopathological findings of the stomach:a “histopathology-oriented” correspondence method helps to understand endoscopic findings. Gastric Cancer 21:573-577, 2018
9)Kato M, Asaka M. Recent knowledge of the relationship between Helicobacter pylori and gastric cancer and recent progress of gastroendoscopic diagnosis and treatment for gastric cancer. Jpn J Clin Oncol 40:828-837, 2010
10)Kim HH, Cho EJ, Noh E, et al. Missed synchronous gastric neoplasm with endoscopic submucosal dissection for gastric neoplasm:experience in our hospital. Dig Endosc 25:32-38, 2013
11)日本胃癌学会(編).胃癌治療ガイドライン,第5版.金原出版,pp 20-24, 2018
12)Uesugi N, Sugai T, Sugimoto R, et al. Clinicopathological and molecular stability and methylation analyses of gastric papillary adenocarcinoma. Pathology 49:596-603, 2017
13)Ogasawara N, Tsukamoto T, Mizoshita T, et al. Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer. Histopathology 49:612-621, 2006